chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Intermenstrual bleeding
Clinical narrative: Brown menstrual spotting mid-cycle.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot  Number: ER 8733) via an unspecified route of administration in the  right arm on 28Apr2021 at 13:30(at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included 3 full term births. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified daily multivitamin, ergocalciferol (VITAMIN D3) and ascorbic acid (VITAMIN C); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW 0170) via an unspecified route of administration in right arm on 07Apr2021 at 13:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 16:00 the patient experienced brown menstrual spotting mid-cycle. It started a few hours after her 2nd dose of the Pfizer COVID-19 vaccine on 28Apr2021. She still had brown spotting on 01May2021. Her period wasn't supposed to start until around 12May2021 and spotting was not a normal part of her cycle. She had never spot before her period. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event brown menstrual spotting mid-cycle was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intermenstrual bleeding
Clinical narrative: Brown menstrual spotting mid-cycle.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot  Number: ER 8733) via an unspecified route of administration in the  right arm on 28Apr2021 at 13:30(at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included 3 full term births. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified daily multivitamin, ergocalciferol (VITAMIN D3) and ascorbic acid (VITAMIN C); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW 0170) via an unspecified route of administration in right arm on 07Apr2021 at 13:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 16:00 the patient experienced brown menstrual spotting mid-cycle. It started a few hours after her 2nd dose of the Pfizer COVID-19 vaccine on 28Apr2021. She still had brown spotting on 01May2021. Her period wasn't supposed to start until around 12May2021 and spotting was not a normal part of her cycle. She had never spot before her period. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event brown menstrual spotting mid-cycle was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle fatigue, Oropharyngeal pain, Pharyngeal swelling, Pruritus
Clinical narrative: migraines; Fever; she felt like her throat was closing up; she couldn't swallow; She couldn't breathe; her lips, nose, face were itchy and tingling; her lips, nose, face were itchy and tingling; throat was sore; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EW1067, Expiry date: unknown), (age at the time of vaccination was 45 years) via unspecified route, on 05May2021 at 14:00 as dose 1, single for COVID-19 immunization. The patient's medical history included and concomitant medication was not reported. On 05May2021 at 14:18, the patient felt like her throat was closing and she couldn't swallow. The patient couldn't breathe, but then later stated she was able to breathe. The patient didn't go into anaphylactic shock or anything. The patient does not have a doctor and got her vaccine at a mass vaccination even so she has no one to reach. The patient couldn't believe that this was the way we were doing this. The patient had a very strong adverse reaction that was more than 15 minutes after the shot and she has already reported this to the CDC through the adverse reaction reporting system but she was scheduled tomorrow for the second shot and she was very concerned that maybe she shouldn't get it because of her symptoms. It was due and concerned. Everyone she has called told her to call Pfizer. The patient doesn't have a primary care. The patient doesn't want to have her throat close up again. The patient doesn't want to cry again because she gets migraines and she cannot handle this, the patient called everyone. The patient doesn't know what to do, no one can tell her and she was scared. The patient couldn't swallow, not breathe, her lips, nose, face were itchy and tingling. The patient had sore throat after the day the patient had a fever. The patient think that it was enough, can't remember if that was everything, the patient did a report about it already. The patient believes it was possible, she gets Botox and it may have interfered she has no idea but she gets Botox injections for her migraines. She didn't mark it on the paper because it said facial fillers and she just did not think about it because she gets the Botox in her head and neck she says that could be it, she does not know. Treatment received included botox for migraine. The outcome of the event she couldn't breathe was recovered and outcome of the other events was unknown.  Follow-up attempts were completed. No further information was expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Dyspnoea, Migraine, Oropharyngeal pain, Paraesthesia
Clinical narrative: migraines; Fever; she felt like her throat was closing up; she couldn't swallow; She couldn't breathe; her lips, nose, face were itchy and tingling; her lips, nose, face were itchy and tingling; throat was sore; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EW1067, Expiry date: unknown), (age at the time of vaccination was 45 years) via unspecified route, on 05May2021 at 14:00 as dose 1, single for COVID-19 immunization. The patient's medical history included and concomitant medication was not reported. On 05May2021 at 14:18, the patient felt like her throat was closing and she couldn't swallow. The patient couldn't breathe, but then later stated she was able to breathe. The patient didn't go into anaphylactic shock or anything. The patient does not have a doctor and got her vaccine at a mass vaccination even so she has no one to reach. The patient couldn't believe that this was the way we were doing this. The patient had a very strong adverse reaction that was more than 15 minutes after the shot and she has already reported this to the CDC through the adverse reaction reporting system but she was scheduled tomorrow for the second shot and she was very concerned that maybe she shouldn't get it because of her symptoms. It was due and concerned. Everyone she has called told her to call Pfizer. The patient doesn't have a primary care. The patient doesn't want to have her throat close up again. The patient doesn't want to cry again because she gets migraines and she cannot handle this, the patient called everyone. The patient doesn't know what to do, no one can tell her and she was scared. The patient couldn't swallow, not breathe, her lips, nose, face were itchy and tingling. The patient had sore throat after the day the patient had a fever. The patient think that it was enough, can't remember if that was everything, the patient did a report about it already. The patient believes it was possible, she gets Botox and it may have interfered she has no idea but she gets Botox injections for her migraines. She didn't mark it on the paper because it said facial fillers and she just did not think about it because she gets the Botox in her head and neck she says that could be it, she does not know. Treatment received included botox for migraine. The outcome of the event she couldn't breathe was recovered and outcome of the other events was unknown.  Follow-up attempts were completed. No further information was expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Pyrexia, Throat tightness
Clinical narrative: migraines; Fever; she felt like her throat was closing up; she couldn't swallow; She couldn't breathe; her lips, nose, face were itchy and tingling; her lips, nose, face were itchy and tingling; throat was sore; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EW1067, Expiry date: unknown), (age at the time of vaccination was 45 years) via unspecified route, on 05May2021 at 14:00 as dose 1, single for COVID-19 immunization. The patient's medical history included and concomitant medication was not reported. On 05May2021 at 14:18, the patient felt like her throat was closing and she couldn't swallow. The patient couldn't breathe, but then later stated she was able to breathe. The patient didn't go into anaphylactic shock or anything. The patient does not have a doctor and got her vaccine at a mass vaccination even so she has no one to reach. The patient couldn't believe that this was the way we were doing this. The patient had a very strong adverse reaction that was more than 15 minutes after the shot and she has already reported this to the CDC through the adverse reaction reporting system but she was scheduled tomorrow for the second shot and she was very concerned that maybe she shouldn't get it because of her symptoms. It was due and concerned. Everyone she has called told her to call Pfizer. The patient doesn't have a primary care. The patient doesn't want to have her throat close up again. The patient doesn't want to cry again because she gets migraines and she cannot handle this, the patient called everyone. The patient doesn't know what to do, no one can tell her and she was scared. The patient couldn't swallow, not breathe, her lips, nose, face were itchy and tingling. The patient had sore throat after the day the patient had a fever. The patient think that it was enough, can't remember if that was everything, the patient did a report about it already. The patient believes it was possible, she gets Botox and it may have interfered she has no idea but she gets Botox injections for her migraines. She didn't mark it on the paper because it said facial fillers and she just did not think about it because she gets the Botox in her head and neck she says that could be it, she does not know. Treatment received included botox for migraine. The outcome of the event she couldn't breathe was recovered and outcome of the other events was unknown.  Follow-up attempts were completed. No further information was expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Headache, Influenza like illness, Pain, Pyrexia
Clinical narrative: chills; burning up with fever; burning up with fever; weak; shaking; life is at stake here; This is a spontaneous report from a contactable consumer (patient). This female patient of unspecified age received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 11Feb2021 as single dose for Covid-19 immunization. Medical history included an autoimmune condition and was severely immunocompromised. Concomitant medications were unknown. The patient previously received the 1st dose of BNT162B2 on 24Jan2021 as single dose for Covid-19 immunization. The patient received first shot of pfizer covid vaccine on 24Jan and was ok. The patient had second shot on 11Feb2021 and then next day on 12Feb2021 burning up with fever, weak, chills and was shaking for several days.  Added she was weak for days. The patient stated she received the flu shot on Sep29 and was told by the pharmacist she should wait at least 7 days after the flu shot before getting the booster. She had an autoimmune condition and was severely immunocompromised. She was bald because of her autoimmune condition. She was concerned about reacting to covid vaccine again. She had lots of underlying medical conditions. The patient was asking how long should she wait after receiving the flu shot before getting booster dose. The patient heard that if get sick after covid vaccine it means it is working. wanting more information. The patient had the 1st vaccine, on the 2nd one, she was sick for 4 days, fever, chills, shaking, weak couldn't even stand up by herself. Her life was at stake here in 2021. She lived alone so, she need to talk to somebody about Pfizer. Outcome of the events were unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Burning sensation, Chills, Near death experience, Pyrexia
Clinical narrative: chills; burning up with fever; burning up with fever; weak; shaking; life is at stake here; This is a spontaneous report from a contactable consumer (patient). This female patient of unspecified age received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 11Feb2021 as single dose for Covid-19 immunization. Medical history included an autoimmune condition and was severely immunocompromised. Concomitant medications were unknown. The patient previously received the 1st dose of BNT162B2 on 24Jan2021 as single dose for Covid-19 immunization. The patient received first shot of pfizer covid vaccine on 24Jan and was ok. The patient had second shot on 11Feb2021 and then next day on 12Feb2021 burning up with fever, weak, chills and was shaking for several days.  Added she was weak for days. The patient stated she received the flu shot on Sep29 and was told by the pharmacist she should wait at least 7 days after the flu shot before getting the booster. She had an autoimmune condition and was severely immunocompromised. She was bald because of her autoimmune condition. She was concerned about reacting to covid vaccine again. She had lots of underlying medical conditions. The patient was asking how long should she wait after receiving the flu shot before getting booster dose. The patient heard that if get sick after covid vaccine it means it is working. wanting more information. The patient had the 1st vaccine, on the 2nd one, she was sick for 4 days, fever, chills, shaking, weak couldn't even stand up by herself. Her life was at stake here in 2021. She lived alone so, she need to talk to somebody about Pfizer. Outcome of the events were unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: chills; burning up with fever; burning up with fever; weak; shaking; life is at stake here; This is a spontaneous report from a contactable consumer (patient). This female patient of unspecified age received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 11Feb2021 as single dose for Covid-19 immunization. Medical history included an autoimmune condition and was severely immunocompromised. Concomitant medications were unknown. The patient previously received the 1st dose of BNT162B2 on 24Jan2021 as single dose for Covid-19 immunization. The patient received first shot of pfizer covid vaccine on 24Jan and was ok. The patient had second shot on 11Feb2021 and then next day on 12Feb2021 burning up with fever, weak, chills and was shaking for several days.  Added she was weak for days. The patient stated she received the flu shot on Sep29 and was told by the pharmacist she should wait at least 7 days after the flu shot before getting the booster. She had an autoimmune condition and was severely immunocompromised. She was bald because of her autoimmune condition. She was concerned about reacting to covid vaccine again. She had lots of underlying medical conditions. The patient was asking how long should she wait after receiving the flu shot before getting booster dose. The patient heard that if get sick after covid vaccine it means it is working. wanting more information. The patient had the 1st vaccine, on the 2nd one, she was sick for 4 days, fever, chills, shaking, weak couldn't even stand up by herself. Her life was at stake here in 2021. She lived alone so, she need to talk to somebody about Pfizer. Outcome of the events were unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: A skin rash on the side of the arms, chest, legs/Light rash on the face; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient).  A 74-year-old female patient received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0162; Expiration Date: 31Jul2021) via an unspecified route of administration in arm left (reported as left arm above elbow) on 10Apr2021 07:30 (at the age at vaccination of 74-year-old) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included, patient received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6203; Expiration Date: 30Jun2021) via an unspecified route of administration in left arm above elbow on 20Mar2021 08:00 (at the age at vaccination of 74-year-old) for covid-19 immunization. On 10Apr2021, patient experienced a skin rash on the side of the arms, chest, legs and light rash on the face. Patient visited her doctor on 19Apr2021 (also reported as Monday) and was prescribed first an ointment triamcinolon for rash. Patient applied for 2 weeks and the rash remained. Patient contacted the doctor again and she prescribed methylprednisolone tablet, USP and rash had remained. Patient's doctor suggested her to visit dermatologist. Outcome of the events was not recovered.   Follow-up attempts are completed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: A skin rash on the side of the arms, chest, legs/Light rash on the face; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient).  A 74-year-old female patient received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0162; Expiration Date: 31Jul2021) via an unspecified route of administration in arm left (reported as left arm above elbow) on 10Apr2021 07:30 (at the age at vaccination of 74-year-old) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included, patient received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6203; Expiration Date: 30Jun2021) via an unspecified route of administration in left arm above elbow on 20Mar2021 08:00 (at the age at vaccination of 74-year-old) for covid-19 immunization. On 10Apr2021, patient experienced a skin rash on the side of the arms, chest, legs and light rash on the face. Patient visited her doctor on 19Apr2021 (also reported as Monday) and was prescribed first an ointment triamcinolon for rash. Patient applied for 2 weeks and the rash remained. Patient contacted the doctor again and she prescribed methylprednisolone tablet, USP and rash had remained. Patient's doctor suggested her to visit dermatologist. Outcome of the events was not recovered.   Follow-up attempts are completed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect route of product administration, Injection site erythema, Injection site inflammation, Injection site swelling
Clinical narrative: she was not given the Pfizer covid vaccine into the  deltoid muscle; her arm is red; her arm is swollen; This is a spontaneous report from a contactable consumer (patient herself). A 40-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0123; Expiration date: unknown) via an unspecified route of administration, administered in Arm Right on 09May2021 as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient's Medical History (including any illness at time of vaccination) was reported as no. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was reported as none. AE(s) following prior vaccinations was reported as no. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0162; Expiration date: unknown) via an unspecified route of administration, administered in Arm Right on 18Apr2021 as DOSE 1, SINGLE for COVID-19 immunization. On 09May2021 it was reported that, the caller explained she got the dose on Sunday and it was not given in the correct site; it was not given the upper deltoid area. She explained that it was given more in the middle of the arm between the elbow and the shoulder, not the bicep but the front of that like the medial triceps area. The location the vaccine was being administered was a mega center but there were military people administering the product. Now her arm was red and swollen and she was concerned she did not get the full dose and will not have full immunity. She had questions about this. The area that was red and swollen was noticed a few hours after getting the shot. There was a half dollar swollen area that was like a welt and was raised and a red area at the inject site. It was not painful. AE(s) did not require a visit to emergency room or physician office. Patient had not relevant tests. The outcome of event her arm is red and her arm is swollen was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Peripheral swelling, Product administered at inappropriate site
Clinical narrative: she was not given the Pfizer covid vaccine into the  deltoid muscle; her arm is red; her arm is swollen; This is a spontaneous report from a contactable consumer (patient herself). A 40-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0123; Expiration date: unknown) via an unspecified route of administration, administered in Arm Right on 09May2021 as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient's Medical History (including any illness at time of vaccination) was reported as no. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was reported as none. AE(s) following prior vaccinations was reported as no. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0162; Expiration date: unknown) via an unspecified route of administration, administered in Arm Right on 18Apr2021 as DOSE 1, SINGLE for COVID-19 immunization. On 09May2021 it was reported that, the caller explained she got the dose on Sunday and it was not given in the correct site; it was not given the upper deltoid area. She explained that it was given more in the middle of the arm between the elbow and the shoulder, not the bicep but the front of that like the medial triceps area. The location the vaccine was being administered was a mega center but there were military people administering the product. Now her arm was red and swollen and she was concerned she did not get the full dose and will not have full immunity. She had questions about this. The area that was red and swollen was noticed a few hours after getting the shot. There was a half dollar swollen area that was like a welt and was raised and a red area at the inject site. It was not painful. AE(s) did not require a visit to emergency room or physician office. Patient had not relevant tests. The outcome of event her arm is red and her arm is swollen was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthritis, Asthenia, Depressed mood, Gait disturbance, Pain
Clinical narrative: Severe pain throughout body; Trouble walking; My arthritis in my fibromyalgia just turned on fourth for force; My arthritis in my fibromyalgia just turned on fourth for force; Arthritis and Fibromylagia; Pain in spine; Pain in legs; pain in hands; Pain in neck; Feeling very tired; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021 at 14:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, arthritis, hypothyroidism and blood pressure high. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and ibuprofen/diphenhydramine citrate (ADVIL PM), both for an unknown indication from an unknown date and were unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 14:00, the patient experienced severe pain throughout her body and had trouble walking, whereas before the vaccine that was fine. The patient reported that her arthritis and fibromyalgia just turned on fourth for force and had been three weeks but still with severe pain. The patient stated that she did not feel like herself. On the same day, the patient also had pain in the spine, legs, hands and neck and was feeling very tired. The patient reported that all these were after the vaccine. The events resulted in doctor or other healthcare professional office/clinic visits. The events resulted in the emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 22Apr2021, the patient underwent a nasal swab test (SARS-CoV-2 test) and the result was unknown. The clinical outcome of the events severe pain throughout the body, trouble walking, arthritis and fibromyalgia just turned on fourth for force, pain in the spine, legs, hands and neck and feeling very tired were not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Skin discolouration, Spinal pain
Clinical narrative: Severe pain throughout body; Trouble walking; My arthritis in my fibromyalgia just turned on fourth for force; My arthritis in my fibromyalgia just turned on fourth for force; Arthritis and Fibromylagia; Pain in spine; Pain in legs; pain in hands; Pain in neck; Feeling very tired; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021 at 14:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, arthritis, hypothyroidism and blood pressure high. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and ibuprofen/diphenhydramine citrate (ADVIL PM), both for an unknown indication from an unknown date and were unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 14:00, the patient experienced severe pain throughout her body and had trouble walking, whereas before the vaccine that was fine. The patient reported that her arthritis and fibromyalgia just turned on fourth for force and had been three weeks but still with severe pain. The patient stated that she did not feel like herself. On the same day, the patient also had pain in the spine, legs, hands and neck and was feeling very tired. The patient reported that all these were after the vaccine. The events resulted in doctor or other healthcare professional office/clinic visits. The events resulted in the emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 22Apr2021, the patient underwent a nasal swab test (SARS-CoV-2 test) and the result was unknown. The clinical outcome of the events severe pain throughout the body, trouble walking, arthritis and fibromyalgia just turned on fourth for force, pain in the spine, legs, hands and neck and feeling very tired were not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthritis, Disease recurrence, Fatigue, Fibromyalgia, Gait disturbance
Clinical narrative: Severe pain throughout body; Trouble walking; My arthritis in my fibromyalgia just turned on fourth for force; My arthritis in my fibromyalgia just turned on fourth for force; Arthritis and Fibromylagia; Pain in spine; Pain in legs; pain in hands; Pain in neck; Feeling very tired; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021 at 14:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, arthritis, hypothyroidism and blood pressure high. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and ibuprofen/diphenhydramine citrate (ADVIL PM), both for an unknown indication from an unknown date and were unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 14:00, the patient experienced severe pain throughout her body and had trouble walking, whereas before the vaccine that was fine. The patient reported that her arthritis and fibromyalgia just turned on fourth for force and had been three weeks but still with severe pain. The patient stated that she did not feel like herself. On the same day, the patient also had pain in the spine, legs, hands and neck and was feeling very tired. The patient reported that all these were after the vaccine. The events resulted in doctor or other healthcare professional office/clinic visits. The events resulted in the emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 22Apr2021, the patient underwent a nasal swab test (SARS-CoV-2 test) and the result was unknown. The clinical outcome of the events severe pain throughout the body, trouble walking, arthritis and fibromyalgia just turned on fourth for force, pain in the spine, legs, hands and neck and feeling very tired were not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Pain, Pain in extremity, SARS-CoV-2 test, Spinal pain
Clinical narrative: Severe pain throughout body; Trouble walking; My arthritis in my fibromyalgia just turned on fourth for force; My arthritis in my fibromyalgia just turned on fourth for force; Arthritis and Fibromylagia; Pain in spine; Pain in legs; pain in hands; Pain in neck; Feeling very tired; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021 at 14:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, arthritis, hypothyroidism and blood pressure high. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and ibuprofen/diphenhydramine citrate (ADVIL PM), both for an unknown indication from an unknown date and were unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 14:00, the patient experienced severe pain throughout her body and had trouble walking, whereas before the vaccine that was fine. The patient reported that her arthritis and fibromyalgia just turned on fourth for force and had been three weeks but still with severe pain. The patient stated that she did not feel like herself. On the same day, the patient also had pain in the spine, legs, hands and neck and was feeling very tired. The patient reported that all these were after the vaccine. The events resulted in doctor or other healthcare professional office/clinic visits. The events resulted in the emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 22Apr2021, the patient underwent a nasal swab test (SARS-CoV-2 test) and the result was unknown. The clinical outcome of the events severe pain throughout the body, trouble walking, arthritis and fibromyalgia just turned on fourth for force, pain in the spine, legs, hands and neck and feeling very tired were not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: Have lost my sense of taste and smell.; Have lost my sense of taste and smell.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 15Apr2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021, the patient experienced loss of sense of taste and smell. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 17Apr2021, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the event loss of sense of taste and smell was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, SARS-CoV-2 test
Clinical narrative: Have lost my sense of taste and smell.; Have lost my sense of taste and smell.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 15Apr2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021, the patient experienced loss of sense of taste and smell. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 17Apr2021, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the event loss of sense of taste and smell was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure fluctuation, Blood pressure increased, Chest discomfort, Chest pain, Dizziness
Clinical narrative: Racing heart; Dizzy; Nausea; Flushed face; Ringing ears; Increase in blood pressure; This is a spontaneous report from a contactable nurse, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 21Apr2021 at 15:45 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergies to grass, trees, mold, cats, dogs, red food dye and also had multiple drug allergies (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN), azelastine (MANUFACTURER UNKNOWN) and fluticasone (FLONASE); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 22Mar2021 at 13:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021,at 16:00, the patient experienced racing heart, dizzy, nausea, flushed face, ringing ears and increase in blood pressure. First time within 20 minutes of second dose then again on 3rd day and every day since progressively lasting longer; the most recent episode had lasted 11 hours. The patient was not able to eat much due to nausea. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the racing heart, dizzy, nausea, flushed face, ringing ears, and increase in blood pressure were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Flushing, Headache, Heart rate abnormal, Nausea
Clinical narrative: Racing heart; Dizzy; Nausea; Flushed face; Ringing ears; Increase in blood pressure; This is a spontaneous report from a contactable nurse, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 21Apr2021 at 15:45 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergies to grass, trees, mold, cats, dogs, red food dye and also had multiple drug allergies (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN), azelastine (MANUFACTURER UNKNOWN) and fluticasone (FLONASE); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 22Mar2021 at 13:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021,at 16:00, the patient experienced racing heart, dizzy, nausea, flushed face, ringing ears and increase in blood pressure. First time within 20 minutes of second dose then again on 3rd day and every day since progressively lasting longer; the most recent episode had lasted 11 hours. The patient was not able to eat much due to nausea. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the racing heart, dizzy, nausea, flushed face, ringing ears, and increase in blood pressure were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus, Tunnel vision
Clinical narrative: Racing heart; Dizzy; Nausea; Flushed face; Ringing ears; Increase in blood pressure; This is a spontaneous report from a contactable nurse, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 21Apr2021 at 15:45 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergies to grass, trees, mold, cats, dogs, red food dye and also had multiple drug allergies (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN), azelastine (MANUFACTURER UNKNOWN) and fluticasone (FLONASE); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 22Mar2021 at 13:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021,at 16:00, the patient experienced racing heart, dizzy, nausea, flushed face, ringing ears and increase in blood pressure. First time within 20 minutes of second dose then again on 3rd day and every day since progressively lasting longer; the most recent episode had lasted 11 hours. The patient was not able to eat much due to nausea. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the racing heart, dizzy, nausea, flushed face, ringing ears, and increase in blood pressure were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness, Flushing, Heart rate
Clinical narrative: Racing heart; Dizzy; Nausea; Flushed face; Ringing ears; Increase in blood pressure; This is a spontaneous report from a contactable nurse, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 21Apr2021 at 15:45 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergies to grass, trees, mold, cats, dogs, red food dye and also had multiple drug allergies (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN), azelastine (MANUFACTURER UNKNOWN) and fluticasone (FLONASE); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 22Mar2021 at 13:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021,at 16:00, the patient experienced racing heart, dizzy, nausea, flushed face, ringing ears and increase in blood pressure. First time within 20 minutes of second dose then again on 3rd day and every day since progressively lasting longer; the most recent episode had lasted 11 hours. The patient was not able to eat much due to nausea. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the racing heart, dizzy, nausea, flushed face, ringing ears, and increase in blood pressure were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.